87 related articles for article (PubMed ID: 23551102)
1. Phosphoinositide 3-kinase gamma in T cell biology and disease therapy.
Fung-Leung WP
Ann N Y Acad Sci; 2013 Mar; 1280():40-3. PubMed ID: 23551102
[TBL] [Abstract][Full Text] [Related]
2. PI3Kδ and PI3Kγ as targets for autoimmune and inflammatory diseases.
Cushing TD; Metz DP; Whittington DA; McGee LR
J Med Chem; 2012 Oct; 55(20):8559-81. PubMed ID: 22924688
[No Abstract] [Full Text] [Related]
3. PI3Kδ and PI3Kγ isoforms have distinct functions in regulating pro-tumoural signalling in the multiple myeloma microenvironment.
Piddock RE; Loughran N; Marlein CR; Robinson SD; Edwards DR; Yu S; Pillinger GE; Zhou Z; Zaitseva L; Auger MJ; Rushworth SA; Bowles KM
Blood Cancer J; 2017 Mar; 7(3):e539. PubMed ID: 28282033
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of phosphoinositide 3-kinase γ attenuates inflammation, obesity, and cardiovascular risk factors.
Wymann MP; Solinas G
Ann N Y Acad Sci; 2013 Mar; 1280():44-7. PubMed ID: 23551103
[TBL] [Abstract][Full Text] [Related]
5. The absence of functional PI3Kgamma prevents leukocyte recruitment and ameliorates DSS-induced colitis in mice.
van Dop WA; Marengo S; te Velde AA; Ciraolo E; Franco I; ten Kate FJ; Boeckxstaens GE; Hardwick JC; Hommes DW; Hirsch E; van den Brink GR
Immunol Lett; 2010 Jun; 131(1):33-9. PubMed ID: 20347874
[TBL] [Abstract][Full Text] [Related]
6. Phosphoinositide 3-kinase γ mediates microglial phagocytosis via lipid kinase-independent control of cAMP.
Schmidt C; Schneble N; Müller JP; Bauer R; Perino A; Marone R; Rybalkin SD; Wymann MP; Hirsch E; Wetzker R
Neuroscience; 2013 Mar; 233():44-53. PubMed ID: 23276671
[TBL] [Abstract][Full Text] [Related]
7. Phosphoinositide 3-kinase gamma controls inflammation-induced myocardial depression via sequential cAMP and iNOS signalling.
Ndongson-Dongmo B; Heller R; Hoyer D; Brodhun M; Bauer M; Winning J; Hirsch E; Wetzker R; Schlattmann P; Bauer R
Cardiovasc Res; 2015 Nov; 108(2):243-53. PubMed ID: 26334033
[TBL] [Abstract][Full Text] [Related]
8. Phosphoinositide 3-kinase γ plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice.
Russo RC; Garcia CC; Barcelos LS; Rachid MA; Guabiraba R; Roffê E; Souza AL; Sousa LP; Mirolo M; Doni A; Cassali GD; Pinho V; Locati M; Teixeira MM
J Leukoc Biol; 2011 Feb; 89(2):269-82. PubMed ID: 21048214
[TBL] [Abstract][Full Text] [Related]
9. Loss of PI3Kγ enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress.
Guo D; Kassiri Z; Basu R; Chow FL; Kandalam V; Damilano F; Liang W; Izumo S; Hirsch E; Penninger JM; Backx PH; Oudit GY
Circ Res; 2010 Nov; 107(10):1275-89. PubMed ID: 20847309
[TBL] [Abstract][Full Text] [Related]
10. Phosphoinositide-3 kinase gamma activity contributes to sepsis and organ damage by altering neutrophil recruitment.
Martin EL; Souza DG; Fagundes CT; Amaral FA; Assenzio B; Puntorieri V; Del Sorbo L; Fanelli V; Bosco M; Delsedime L; Pinho JF; Lemos VS; Souto FO; Alves-Filho JC; Cunha FQ; Slutsky AS; Ruckle T; Hirsch E; Teixeira MM; Ranieri VM
Am J Respir Crit Care Med; 2010 Sep; 182(6):762-73. PubMed ID: 20508212
[TBL] [Abstract][Full Text] [Related]
11. Phosphoinositide 3-kinase gamma (PI3Kgamma) inhibitors for the treatment of inflammation and autoimmune disease.
Venable JD; Ameriks MK; Blevitt JM; Thurmond RL; Fung-Leung WP
Recent Pat Inflamm Allergy Drug Discov; 2010 Jan; 4(1):1-15. PubMed ID: 20017720
[TBL] [Abstract][Full Text] [Related]
12. PI3Kγ kinase activity is required for optimal T-cell activation and differentiation.
Ladygina N; Gottipati S; Ngo K; Castro G; Ma JY; Banie H; Rao TS; Fung-Leung WP
Eur J Immunol; 2013 Dec; 43(12):3183-96. PubMed ID: 24030559
[TBL] [Abstract][Full Text] [Related]
13. Evolution of PI3Kγ and δ Inhibitors for Inflammatory and Autoimmune Diseases.
Perry MWD; Abdulai R; Mogemark M; Petersen J; Thomas MJ; Valastro B; Westin Eriksson A
J Med Chem; 2019 May; 62(10):4783-4814. PubMed ID: 30582813
[TBL] [Abstract][Full Text] [Related]
14. Loss of phosphoinositide 3-kinase gamma decreases migration and activation of phagocytes but not T cell activation in antigen-induced arthritis.
Gruen M; Rose C; König C; Gajda M; Wetzker R; Bräuer R
BMC Musculoskelet Disord; 2010 Apr; 11():63. PubMed ID: 20374644
[TBL] [Abstract][Full Text] [Related]
15. Importance of phosphoinositide 3-kinase gamma in the host defense against pneumococcal infection.
Maus UA; Backi M; Winter C; Srivastava M; Schwarz MK; Rückle T; Paton JC; Briles D; Mack M; Welte T; Maus R; Bohle RM; Seeger W; Rommel C; Hirsch E; Lohmeyer J; Preissner KT
Am J Respir Crit Care Med; 2007 May; 175(9):958-66. PubMed ID: 17322108
[TBL] [Abstract][Full Text] [Related]
16. Discovery of N-{5-[3-(3-hydroxypiperidin-1-yl)-1,2,4-oxadiazol-5-yl]-4-methyl-1,3-thiazol-2-yl}acetamide (TASP0415914) as an orally potent phosphoinositide 3-kinase γ inhibitor for the treatment of inflammatory diseases.
Oka Y; Yabuuchi T; Oi T; Kuroda S; Fujii Y; Ohtake H; Inoue T; Wakahara S; Kimura K; Fujita K; Endo M; Taguchi K; Sekiguchi Y
Bioorg Med Chem; 2013 Dec; 21(24):7578-83. PubMed ID: 24262886
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8
Dwyer CJ; Arhontoulis DC; Rangel Rivera GO; Knochelmann HM; Smith AS; Wyatt MM; Rubinstein MP; Atkinson C; Thaxton JE; Neskey DM; Paulos CM
Eur J Immunol; 2020 Sep; 50(9):1386-1399. PubMed ID: 32383488
[TBL] [Abstract][Full Text] [Related]
18. Targeting phosphatidylinositol 3-kinase gamma (PI3Kγ): Discovery and development of its selective inhibitors.
Zhu J; Li K; Yu L; Chen Y; Cai Y; Jin J; Hou T
Med Res Rev; 2021 May; 41(3):1599-1621. PubMed ID: 33300614
[TBL] [Abstract][Full Text] [Related]
19. Discovery and optimization of a series of 2-aminothiazole-oxazoles as potent phosphoinositide 3-kinase γ inhibitors.
Oka Y; Yabuuchi T; Fujii Y; Ohtake H; Wakahara S; Matsumoto K; Endo M; Tamura Y; Sekiguchi Y
Bioorg Med Chem Lett; 2012 Dec; 22(24):7534-8. PubMed ID: 23122859
[TBL] [Abstract][Full Text] [Related]
20. SAR studies around a series of triazolopyridines as potent and selective PI3Kγ inhibitors.
Bell K; Sunose M; Ellard K; Cansfield A; Taylor J; Miller W; Ramsden N; Bergamini G; Neubauer G
Bioorg Med Chem Lett; 2012 Aug; 22(16):5257-63. PubMed ID: 22819766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
